Andrew Stokes1, Yu Ni2, Samuel H Preston3. 1. Department of Global Health and Center for Global Health and Development, Boston University School of Public Health, Boston, Massachusetts. Electronic address: acstokes@bu.edu. 2. Department of Epidemiology, University of Washington, Seattle, Washington. 3. Department of Sociology and Population Studies Center, University of Pennsylvania, Philadelphia, Pennsylvania.
Abstract
INTRODUCTION: Estimates of obesity prevalence based on current BMI are an important but incomplete indicator of the total effects of obesity on a population. METHODS: In this study, data on current BMI and maximum BMI were used to estimate prevalence and trends in lifetime obesity status, defined using the categories never (maximum BMI ≤30 kg/m2), former (maximum BMI ≥30 kg/m2 and current BMI ≤30 kg/m2), and current obesity (current BMI ≥30 kg/m2). Prevalence was estimated for the period 2013-2014 and trends for the period 1988-2014 using data from the National Health and Nutrition Examination Survey. Predictors of lifetime weight status and the association between lifetime weight categories and prevalent disease status were also investigated using multivariable regression. RESULTS: A total of 50.8% of American males and 51.6% of American females were ever obese in 2013-2014. The prevalence of lifetime obesity exceeded the prevalence of current obesity by amounts that were greater for males and for older persons. The gap between the two prevalence values has risen over time. By 2013-2014, a total of 22.0% of individuals who were not currently obese had formerly been obese. For each of eight diseases considered, prevalence was higher among the formerly obese than among the never obese. CONCLUSIONS: A larger fraction of the population is affected by obesity and its health consequences than is suggested in prior studies based on current BMI alone. Weight history should be incorporated into routine health surveillance of the obesity epidemic for a full accounting of the effects of obesity on the U.S.
INTRODUCTION: Estimates of obesity prevalence based on current BMI are an important but incomplete indicator of the total effects of obesity on a population. METHODS: In this study, data on current BMI and maximum BMI were used to estimate prevalence and trends in lifetime obesity status, defined using the categories never (maximum BMI ≤30 kg/m2), former (maximum BMI ≥30 kg/m2 and current BMI ≤30 kg/m2), and current obesity (current BMI ≥30 kg/m2). Prevalence was estimated for the period 2013-2014 and trends for the period 1988-2014 using data from the National Health and Nutrition Examination Survey. Predictors of lifetime weight status and the association between lifetime weight categories and prevalent disease status were also investigated using multivariable regression. RESULTS: A total of 50.8% of American males and 51.6% of American females were ever obese in 2013-2014. The prevalence of lifetime obesity exceeded the prevalence of current obesity by amounts that were greater for males and for older persons. The gap between the two prevalence values has risen over time. By 2013-2014, a total of 22.0% of individuals who were not currently obese had formerly been obese. For each of eight diseases considered, prevalence was higher among the formerly obese than among the never obese. CONCLUSIONS: A larger fraction of the population is affected by obesity and its health consequences than is suggested in prior studies based on current BMI alone. Weight history should be incorporated into routine health surveillance of the obesity epidemic for a full accounting of the effects of obesity on the U.S.
Authors: Amy Berrington de Gonzalez; Patricia Hartge; James R Cerhan; Alan J Flint; Lindsay Hannan; Robert J MacInnis; Steven C Moore; Geoffrey S Tobias; Hoda Anton-Culver; Laura Beane Freeman; W Lawrence Beeson; Sandra L Clipp; Dallas R English; Aaron R Folsom; D Michal Freedman; Graham Giles; Niclas Hakansson; Katherine D Henderson; Judith Hoffman-Bolton; Jane A Hoppin; Karen L Koenig; I-Min Lee; Martha S Linet; Yikyung Park; Gaia Pocobelli; Arthur Schatzkin; Howard D Sesso; Elisabete Weiderpass; Bradley J Willcox; Alicja Wolk; Anne Zeleniuch-Jacquotte; Walter C Willett; Michael J Thun Journal: N Engl J Med Date: 2010-12-02 Impact factor: 91.245
Authors: Philip R Schauer; Deepak L Bhatt; John P Kirwan; Kathy Wolski; Stacy A Brethauer; Sankar D Navaneethan; Ali Aminian; Claire E Pothier; Esther S H Kim; Steven E Nissen; Sangeeta R Kashyap Journal: N Engl J Med Date: 2014-03-31 Impact factor: 91.245
Authors: Allison A Hedley; Cynthia L Ogden; Clifford L Johnson; Margaret D Carroll; Lester R Curtin; Katherine M Flegal Journal: JAMA Date: 2004-06-16 Impact factor: 56.272
Authors: Lorne J Hofseth; James R Hebert; Anindya Chanda; Hexin Chen; Bryan L Love; Maria M Pena; E Angela Murphy; Mathew Sajish; Amit Sheth; Phillip J Buckhaults; Franklin G Berger Journal: Nat Rev Gastroenterol Hepatol Date: 2020-02-21 Impact factor: 46.802
Authors: Mark D Hayward; Mateo P Farina; Yuan S Zhang; Jung Ki Kim; Eileen M Crimmins Journal: J Gerontol B Psychol Sci Soc Sci Date: 2021-10-30 Impact factor: 4.942
Authors: David A Katzka; Prasad G Iyer; Don C Codipilly; Tarek Sawas; Lovekirat Dhaliwal; Michele L Johnson; Ramona Lansing; Kenneth K Wang; Cadman L Leggett Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-12-11 Impact factor: 4.090
Authors: Chanita Hughes Halbert; Melanie Jefferson; Lynne Nemeth; Cathy L Melvin; Paul Nietert; LaShanta Rice; Kemi M Chukwuka Journal: Prev Med Rep Date: 2017-11-29
Authors: Jennifer A Emond; Lucy K Tantum; Diane Gilbert-Diamond; Sunny Jung Kim; Reina K Lansigan; Sara Benjamin Neelon Journal: BMC Public Health Date: 2018-10-29 Impact factor: 3.295